chevron_leftBack
A
As of 6 June 2026, Active Biotech AB has a market cap of $15.92M USD, ranking #38606 globally and #585 in Sweden.
It ranks #3445 in the Healthcare sector, and #674 in the Biotechnology industry.
Key Stats
Market Cap
$15.92MUSD
149.23M SEK
Company Profile
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -6.8% | -99% | 11% | 46% | 6.1% | -67% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
ACTI
ISIN: SE0029278555
Shares Out.:
Shares Outstanding:
26.361M1
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
6.71 SEK | |
|
0GQU
ISIN: SE0029278555
|
6.08 SEK |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
STO: VIMIAN
|
$1.59B
10K%
14.9B SEK
|
43.7
|
|
STO: BINV
|
$151.29M
850%
1.42B SEK
|
-
|
|
STO: BICO
|
$141.71M
790%
1.33B SEK
|
-
|
|
STO: CINPHA
|
$60.38M
279%
565.9M SEK
|
-
|
|
STO: IVACC
|
$41.82M
163%
391.94M SEK
|
-
|
|
NGM: BIOWKS
|
$33.1M
108%
310.2M SEK
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: AMGN
|
$182.42B
1M%
|
23.9
|
|
NASDAQ: GILD
|
$159.92B
1M%
|
19.0
|
|
EBR: ARGX
|
$48.08B
302K%
41.39B EUR
|
39.9
|
|
KRX: 207940
|
$44.48B
279K%
68.19T KRW
|
35.5
|
|
ASX: CSL
|
$43.01B
270K%
60.27B AUD
|
29.3
|
|
SIX: LONN
|
$42.72B
268K%
33.71B CHF
|
37.2
|
chevron_leftBack